NK cell-mediated effector functions are regulated by a delicate balance bet
ween positive and negative signals. Receptors transmitting negative signals
upon engagement with target cell MHC class I molecules have been character
ized in detail in recent years. In contrast, less information is available
about receptor-ligand interactions involved in the transmission of positive
or "triggering" signals to NK cells. Recently, it has been described that
murine NK cells are triggered by the costimulatory molecules CD80, CD86, an
d CD40. Using NK cell lines derived from PBMC as effecters, we demonstrate
that the human CD80 and CD86 gene products can function as triggering molec
ules for NK cell-mediated cytotoxicity. Expression of human CD80 or CD86 mo
lecules in murine B16.F1 melanoma cells rendered these significantly more s
usceptible to lysis by human NK cell lines. Blocking of the transfected gen
e products with specific mAb reduced lysis levels to that of nontransfected
control cell lines. Triggering of human Mt cells by CD80 and CD86 appeared
to be independent of CD28 and CTLA-4 at least as determined by the reagent
s used in the present study, because the expression of these molecules coul
d not be detected on the NK cell lines by either flow cytometry or in redir
ected lysis assays. Thus, human NR cells may use receptors other than CD28
and CTLA-4 in their interactions with CD80 and CD86 molecules. Alternativel
y, interactions may involve variants of CD28 land possibly CTLA-4) that are
not recognized by certain anti-CD28 mAb.